We then examined the changes in the expression of key molecules (p-AKT, p-mTOR, YAP1, p-P65, and β-catenin), which AML common signaling pathways in AML, after SENP1 knockdown. This evidence concerns the gene AKT1 and acute myeloid leukemia.